11 unknown. 11 Phase 2, 3 Phase 1, 2 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 11 | Unknown 11 |
| Phase 1 | 3 | Unknown 3 |
| Phase 3 | 2 | Unknown 2 |
Follow Puerperal Disorders: new trials by email Literature Review of Puerperal Disorders trials Research Report on Puerperal Disorders
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Phase II Study of HS-10353 in Participants With Postpartum Depression HS-10353 Capsules 30 mg, Oral, QN for 14 days, HS-10353 Capsules 50 mg, Oral, QN for 14 days, HS-10353 Capsules matching placebo, 30mg, Oral, QN for 14 days. - Postpartum Depression | Phase 2 | Unknown | Jiangsu Hansoh Pharmaceutical Co., Ltd. | 96 | 2023-08-31 | 2023-07-10 |
| Prevention of Primary Postpartum Haemorrhage Misoprostol, Oxytocin - Primary, Post Partum Hemorrhage | Phase 2 | Unknown | Islamabad Medical and Dental College | 180 | 2021-02-03 | 2021-02-25 |
| Tranexamic Acid for the Prevention of Postpartum Haemorrhage Tranexamic Acid 100 milligram/Milliliter, Oxytocin - Postpartum Hemorrhage | Phase 1 / Phase 2 | Unknown | Benha University | 60 | 2020-01-01 | 2021-01-13 |
| Intrauterine Misoprostol Versus Rectal Misoprostol in Reducing Blood Loss During Cesarean Section Misoprostol - Hemorrhage, Postpartum | Phase 2 | Unknown | Cairo University | 98 | 2018-11-15 | 2020-03-18 |
| Use of TXA to Prevent Postpartum Hemorrhage TXA (1g), Placebo (0.9% saline) - Post Partum Hemorrhage | Phase 2 | Unknown | Sunnybrook Health Sciences Centre | 31 | 2018-03-06 | 2022-09-13 |
| Prophylactic Oxytocin Before Versus After Placental Delivery to Reduce Blood Loss in Vaginal Delivery oxytocin - Postpartum Hemorrhage | Phase 2 | Unknown | Ain Shams Maternity Hospital | 400 | 2016-08-01 | 2017-03-15 |
| Sublingual Misoprostol to Reduce Blood Loss During Elective Cesarean Delivery Misoprostol Oral Tablet, Ranitidine Oral Tablet - Hemorrhage Postpartum | Phase 2 | Unknown | Ain Shams Maternity Hospital | 158 | 2016-07-01 | 2017-05-04 |
| Tranexamic Acid and Ethamsylate For Preventing PPH in Patient Undergoing LSCS at High Risk For PPH Tranexamic Acid and Ethamsylate - Postpartum Hemorrhage | Phase 1 / Phase 2 | Unknown | Ahmed Alanwar | 64 | 2015-11-01 | 2015-11-30 |
| Study of a Probiotic Strain to Prevent Mastitis and to Eradicate GBS Colonization Lactobacillus salivarius PS2, Excipient (milk powder) - Mastitis | Phase 1 / Phase 2 | Unknown | Universidad Complutense de Madrid | 100 | 2011-11-01 | 2012-01-12 |
| Diet and Lifestyle Intervention Study in Postpartum Women in China Diet and Lifestyle Intervention in Chinese Postpartum Women - Puerperal Infection, Fever | Phase 2 / Phase 3 | Unknown | Huazhong University of Science and Technology | 1600 | 2009-06-01 | 2009-12-24 |
| Outcome of Postnatal Depression Screening Using Edinburgh Postnatal Depression Scale Edinburgh Postnatal Depression Scale - Depression, Postpartum | Phase 2 / Phase 3 | Unknown | Chinese University of Hong Kong | 460 | 2005-10-01 | 2007-04-05 |
Postpartum Hemorrhage (7) · Depression, Postpartum (2) · Anemia (1) · Breast Diseases (1) · Constipation (1) · Fever (1) · Fissure in Ano (1) · Hemorrhage (1) · Hemorrhoids (1) · Mastitis (1) · Oral Ulcer (1) · Puerperal Infection (1)
Female Urogenital Diseases and Pregnancy Complications (11) · Pregnancy Complications (11) · Urogenital Diseases (11) · Pathological Conditions, Signs and Symptoms (8) · Obstetric Labor Complications (7) · Pathologic Processes (7) · Uterine Hemorrhage (7) · Hemorrhage (6) · Depressive Disorder (2) · Mental Disorders (2) · Mood Disorders (2) · Skin Diseases (2) · Skin and Connective Tissue Diseases (2) · Anus Diseases (1)
Misoprostol (3) · Oxytocin (3) · Arthotec (1) · Control Groups (1) · Diet (1) · Ethamsylate (1) · Excipients (1) · Multicenter Studies as Topic (1) · Psychiatric Status Rating Scales (1) · Ranitidine (1) · Sodium Chloride (1) · Tranexamic Acid (1) · lactitol (1)
Ain Shams Maternity Hospital (2) · Ahmed Alanwar (1) · Benha University (1) · Cairo University (1) · Chinese University of Hong Kong (1) · Huazhong University of Science and Technology (1) · Islamabad Medical and Dental College (1) · Jiangsu Hansoh Pharmaceutical Co., Ltd. (1) · Sunnybrook Health Sciences Centre (1) · Universidad Complutense de Madrid (1)
Egypt (4) · China (2) · Canada (1) · Pakistan (1) · Spain (1)
Abubaker M Elnashar, MD (1) · Amr Yehia, MD, MRCOG (1) · Asim Q Alam, MD, FRCPC (1) · Dominic TS Lee, M.D. (1) · Juan M Rodriguez, PhD (1) · Liegang Liu, PhD (1) · Shirley SL Leung, MPH (1) · Stephen Choi, MD,FRCPC,MSc (1)
PMID 20187965, PMID 20884642, PMID 26611780, PMID 29025850, PMID 32987448, PMID 33064852, PMID 36934142